Title of article
Paresis Following Type A Botulinum Toxin (Dysport) Injection: A Case Report
Author/Authors
Salarian ، Sara Department of Anesthesiology - School of Medicine, Critical Care Quality Improvement Research Center, Shahid Modarres Hospital - Shahid Beheshti University of Medical Sciences , Raoufi ، Masoomeh Department of Radiology - School of Medicine, Imam Hossein Hospital - Shahid Beheshti University of Medical Sciences , Asgari ، Sogol Department of Anesthesiology - School of Medicine, Loghman Hakim Hospital - Shahid Beheshti University of Medical Sciences , Behnaz ، Faranak Department of Anesthesiology - School of Medicine, Shohada-e-Tajrish Hospital - Shahid Beheshti University of Medical Sciences , Safarpour Lima ، Behnam Department of Neurology - Imam Hossein Hospital, School of Medicine - Shahid Beheshti University of Medical Sciences
From page
1
To page
3
Abstract
Primary hyperhidrosis (PH) is a condition characterized by excessive sweating. Primary treatment options include antiperspirants or anticholinergics for symptomatic relief, while axillary and palmar hyperhidrosis can be addressed with surgery. Botulinum toxin type A (BTX-A) is a significant treatment option for these patients. This toxin inhibits the release of acetylcholine, preventing overactive eccrine sweat glands from causing excessive sweating. Despite its effectiveness in treating various neurological and cosmetic conditions, Botox may pose the risk of severe side effects resulting from local or systemic drug release. We report the case of a 21-year-old woman who developed weakness in all four limbs, dyspnea, dysphagia, and blurred vision two weeks after botulinum toxin injection for hyperhidrosis treatment.
Keywords
Paresis , Paralysis , Botulinum , Toxin , Treatment
Journal title
Journal of Cellular and Molecular Anesthesia
Journal title
Journal of Cellular and Molecular Anesthesia
Record number
2774241
Link To Document